Screener
Iovance Biotherapeutics, Inc. IOVA Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Depreciation and amortization of property and equipment | 6,607 | 5,950 |
| Deferred tax benefit | (2,038) | 150 |
| Excess and obsolescence reserve | 2,808 | 8,311 |
| Accretion of discounts and premiums on investments | (2,533) | (4,149) |
| Loss on asset disposals | 670 | 44 |
| Gain on loan forgiveness | (1,000) | — |
| Changes in assets and liabilities: | — | |
| Prepaid expenses, other assets and long-term assets | 4,444 | (10,138) |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Iovance Biotherapeutics, Inc. (IOVA) reported accretion (amortization) of discounts and premiums, investments of $1.41M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Iovance Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 29.5% year-over-year, from $2M to $1.41M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 6.2% compound annual growth rate (CAGR), from -$6.01M to $7.2M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- Represents the periodic adjustment to the carrying value of investment securities to reflect the amortization of premiums or the accretion of discounts over the life of the instrument. This adjustment aligns the investment's book value with its effective interest rate. It provides insight into the company's treasury management and the yield profile of its cash equivalents.
Ask your AI about Iovance Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude